Gallstones

Willemijntje A. Hoogerwerf, Roger D. Soloway

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

This review summarizes the main advances made in the epidemiology, pathogenesis, and medical treatment of gallstone disease in the past year. Whether rapid weight reduction can precipitate gallstone formation is still debated. Phospholipase A2-II seems to play an interesting role in the pathogenesis of multiple cholesterol stone formation, and ursodeoxycholic acid may partially halt the formation of multiple cholesterol stones by mediating an anti-inflammatory effect on the gallbladder. Bacterial infections may contribute to gallstone formation, perhaps through secretion of biofilm. The combination of ursodeoxycholic acid and simvastatin for the resolution and prevention of gallstones is promising, but larger studies are needed.

Original languageEnglish (US)
Pages (from-to)442-447
Number of pages6
JournalCurrent Opinion in Gastroenterology
Volume15
Issue number5
DOIs
StatePublished - 1999

Fingerprint

Gallstones
Ursodeoxycholic Acid
Group II Phospholipases A2
Cholesterol
Simvastatin
Biofilms
Gallbladder
Bacterial Infections
Weight Loss
Epidemiology
Anti-Inflammatory Agents

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Hoogerwerf, W. A., & Soloway, R. D. (1999). Gallstones. Current Opinion in Gastroenterology, 15(5), 442-447. https://doi.org/10.1097/00001574-199909000-00012

Gallstones. / Hoogerwerf, Willemijntje A.; Soloway, Roger D.

In: Current Opinion in Gastroenterology, Vol. 15, No. 5, 1999, p. 442-447.

Research output: Contribution to journalArticle

Hoogerwerf, WA & Soloway, RD 1999, 'Gallstones', Current Opinion in Gastroenterology, vol. 15, no. 5, pp. 442-447. https://doi.org/10.1097/00001574-199909000-00012
Hoogerwerf, Willemijntje A. ; Soloway, Roger D. / Gallstones. In: Current Opinion in Gastroenterology. 1999 ; Vol. 15, No. 5. pp. 442-447.
@article{7dbe9b6429b94646a0693344a39663ac,
title = "Gallstones",
abstract = "This review summarizes the main advances made in the epidemiology, pathogenesis, and medical treatment of gallstone disease in the past year. Whether rapid weight reduction can precipitate gallstone formation is still debated. Phospholipase A2-II seems to play an interesting role in the pathogenesis of multiple cholesterol stone formation, and ursodeoxycholic acid may partially halt the formation of multiple cholesterol stones by mediating an anti-inflammatory effect on the gallbladder. Bacterial infections may contribute to gallstone formation, perhaps through secretion of biofilm. The combination of ursodeoxycholic acid and simvastatin for the resolution and prevention of gallstones is promising, but larger studies are needed.",
author = "Hoogerwerf, {Willemijntje A.} and Soloway, {Roger D.}",
year = "1999",
doi = "10.1097/00001574-199909000-00012",
language = "English (US)",
volume = "15",
pages = "442--447",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Gallstones

AU - Hoogerwerf, Willemijntje A.

AU - Soloway, Roger D.

PY - 1999

Y1 - 1999

N2 - This review summarizes the main advances made in the epidemiology, pathogenesis, and medical treatment of gallstone disease in the past year. Whether rapid weight reduction can precipitate gallstone formation is still debated. Phospholipase A2-II seems to play an interesting role in the pathogenesis of multiple cholesterol stone formation, and ursodeoxycholic acid may partially halt the formation of multiple cholesterol stones by mediating an anti-inflammatory effect on the gallbladder. Bacterial infections may contribute to gallstone formation, perhaps through secretion of biofilm. The combination of ursodeoxycholic acid and simvastatin for the resolution and prevention of gallstones is promising, but larger studies are needed.

AB - This review summarizes the main advances made in the epidemiology, pathogenesis, and medical treatment of gallstone disease in the past year. Whether rapid weight reduction can precipitate gallstone formation is still debated. Phospholipase A2-II seems to play an interesting role in the pathogenesis of multiple cholesterol stone formation, and ursodeoxycholic acid may partially halt the formation of multiple cholesterol stones by mediating an anti-inflammatory effect on the gallbladder. Bacterial infections may contribute to gallstone formation, perhaps through secretion of biofilm. The combination of ursodeoxycholic acid and simvastatin for the resolution and prevention of gallstones is promising, but larger studies are needed.

UR - http://www.scopus.com/inward/record.url?scp=0032789961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032789961&partnerID=8YFLogxK

U2 - 10.1097/00001574-199909000-00012

DO - 10.1097/00001574-199909000-00012

M3 - Article

C2 - 17023987

AN - SCOPUS:0032789961

VL - 15

SP - 442

EP - 447

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 5

ER -